Concepedia

Isobel Pearson

IP

4

Publications

139

Citations

4

H-Index

2003

Active since

Affiliations

RTI Health Solutions(Current)

Isobel Pearson is an author at RTI Health Solutions specializing in medicine, immunology, and hematology.

Top concepts

MedicineGoutBiologyOncologyHematologyImmunologyBacteriologyBiochemistryBiosynthesisMicrobiology

Publications per year

2003–2015

4

Publications

4

A Mutant of <i>Paracoccus denitrificans</i> with Disrupted Genes Coding for Cytochrome <i>c</i> <sub>550</sub> and Pseudoazurin Establishes These Two Proteins as the In Vivo Electron Donors to Cytochrome <i>cd</i> <sub>1</sub> Nitrite Reductase

Isobel Pearson, M. Dudley Page, Rob J. M. van Spanning et al. · Journal of Bacteriology · 2003 · 60 citations · Full text

Nitrite Reductase, Bacteriology, Molecular Biology +17

Cost-effectiveness of febuxostat in chronic gout

S Beard, Birgitta G. von Scheele, George Nuki et al. · The European Journal of Health Economics · 2013 · 48 citations

Chronic Gout, Therapeutic Controversy, Treatment Option +3

Cost Effectiveness of Ofatumumab Plus Chlorambucil in First-Line Chronic Lymphocytic Leukaemia in Canada

William L. Herring, Isobel Pearson, Molly Purser et al. · PharmacoEconomics · 2015 · 16 citations

Hematological Malignancy, Lymphoid Neoplasia, Ofatumumab Plus Chlorambucil +7

Development and validation of a cost–utility model for Type 1 diabetes mellitus

Sorrel Wolowacz, Isobel Pearson, P. A. Shannon et al. · Diabetic Medicine · 2014 · 15 citations

Rows per page

1–4 of 4